Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CranewareFRA:3X6 +2.58%84 EV-to-EBIT is 21.80 as of Aug. 30, 2026, which is 43% below its 10-year median of 38.00. GuruFocus rates FRA:3X6 with a GF Score™ of 84/100 and a GF Value™ of €22.83 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Craneware ranks worse than 66.46% on this metric.
The historical rank and industry rank for Craneware's EV-to-EBIT or its related term are showing as below:
FRA:3X6'
s EV-to-EBIT Range Over the Past 10 Years
Min: 18.67 Med: 38 Max: 66.52
Current: 21.68
During the past 13 years, the highest EV-to-EBIT of Craneware was 66.52. The lowest was 18.67. And the median was 38.00.
FRA:3X6's EV-to-EBIT is ranked worse than 66.46% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 15.75
vs FRA:3X6: 21.68
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Craneware's Enterprise Value for the quarter that ended in Dec. 2025 was €755.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Craneware's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €25.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Craneware EV-to-EBIT Related Terms
Craneware EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Craneware's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Craneware's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Craneware EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Craneware's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Craneware's EV-to-EBIT falls into.
Craneware's current Enterprise Value is €544.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Craneware's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €25.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Craneware (FRA:3X6) has a EV-to-EBIT of 21.80 as of Aug. 30, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Craneware and its competitors. This is 43% below median its historical median of 38.00. Over the past decade, Craneware's EV-to-EBIT has ranged from 18.67 to 66.52. According to the industry distribution chart, Craneware ranks #317 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 66.5%.
Is Craneware's EV-to-EBIT too high?
Craneware's current EV-to-EBIT of 21.80 is 43% below median its 10-year median of 38.00. Over the past 10 years, this metric has ranged from a low of 18.67 to a high of 66.52. The Healthcare Providers & Services industry median EV-to-EBIT is 15.75. Craneware's value of 21.80 is 38.4% above this industry median. Based on the distribution chart, Craneware ranks #317 out of 477 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Craneware has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Craneware's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Craneware ranks #317 out of 477 companies for EV-to-EBIT. This places Craneware in the lower half of its industry. The industry median EV-to-EBIT is 15.75. Craneware's value of 21.80 is 38.4% above this benchmark. Historically, Craneware's own EV-to-EBIT has ranged from 18.67 to 66.52 over the past decade. While the company's 10-year median is 38.00 vs. the industry median of 15.75, Craneware has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.75, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Craneware's current EV-to-EBIT of 21.80 is 38.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Craneware and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Craneware's current EV-to-EBIT is 21.80, which is 43% below median its own 10-year median of 38.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Craneware stock overvalued right now?
Based on GuruFocus' analysis, Craneware (FRA:3X6) is currently considered Significantly Undervalued. The stock's GF Value™ is €22.83, compared to a current price of €15.90 — trading 30.4% below its estimated fair value. The current EV-to-EBIT is 21.80, which is 43% below median its 10-year median of 38.00 and 38.4% above the Healthcare Providers & Services industry median of 15.75. Craneware's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Craneware (FRA:3X6), the current EV-to-EBIT is 21.80 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Craneware (FRA:3X6) Overvalued in 2026?
Based on GuruFocus' analysis, Craneware stock appears to be undervalued.
The current stock price of €15.90 is trading 30.4% below its estimated GF Value™ of €22.83.
GuruFocus considers Craneware to be Significantly Undervalued.
Key valuation signals for FRA:3X6:
EV-to-EBIT: 21.80 (43% below median its 10-year median of 38.00)
GF Value™: €22.83 vs. price of €15.90 (30.4% below fair value)
Industry Position: 38.4% above the Healthcare Providers & Services median (#317 of 477)
No single metric tells the full story. See the FRA:3X6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Craneware PLC provides automated revenue integrity solutions that improve financial performance for healthcare organizations. Its activities include the development, licensing, and ongoing support of computer software for the US healthcare industry. It is engaged in the sale of software licenses, white labelling, and professional services (including installation) to hospitals within the USA. The company recognizes its revenues from the sale of and distribution agreements relating to software licenses and professional services.
84GF Score
Get the complete analysis for FRA:3X6
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3X6 has been successfully added to your 
